Work

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

Year: 2011

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e318226b5fa

Authors: José Rodrigues-Pereira, Joo-Hang Kim, Manuel Magallanes, Dae Ho Lee, Jie Wang, Vinod Ganju, Luis Martínez-Barrera, Helen Barraclough, Maximiliano van Kooten, Mauro Orlando

Institutions: Yonsei University Health System, Yonsei Cancer Hospital, Asan Medical Center, University of Ulsan, Peking University Cancer Hospital, Frankston Hospital, Instituto Nacional de Enfermedades Respiratorias, Eli Lilly (Australia)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1964370859

FWCI: 6.947

Cites: 32

Cited by: 94

Related to: 10